36 Publications (Page 2 of 2)
2011
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
Hahn, Noah⋅Hahn, Noah⋅Stadler, Walter M⋅Stadler, Walter⋅Zon, Robin T⋅Zon, Robin⋅Waterhouse, David⋅Waterhouse, David⋅Picus, Joel⋅Picus, Joel⋅Nattam, Sreenivasa⋅Nattam, Sreenivasa⋅Johnson, Cynthia⋅Johnson, Cynthia S⋅Perkins, Susan⋅Perkins, Susan M⋅Waddell, Mary⋅Waddell, Mary J⋅Sweeney, Christopher and Sweeney, Christopher J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 12), pp. 1525-30, 2011/Apr/20. | Journal Article
 
Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer.
Flanagan, J⋅Gray, P K⋅Hahn, Noah⋅Hayes, J⋅Myers, L J⋅Carney-Doebbeling, C and Sweeney, Christopher J
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 22, (no. 4), pp. 801-7, 2011/Apr. | Journal Article
 
Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.
Galsky, Matthew⋅Hahn, Noah⋅Rosenberg, Jonathan⋅Sonpavde, Guru⋅Hutson, Thomas⋅Oh, William K⋅Dreicer, Robert⋅Vogelzang, Nicholas⋅Sternberg, Cora N⋅Bajorin, Dean F and Bellmunt, Joaquim
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 17), pp. 2432-8, 2011/Jun/10. | Journal Article
2010
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium.
Sonpavde, Guru⋅Sternberg, Cora N⋅Rosenberg, Jonathan E⋅Hahn, Noah⋅Galsky, Matthew D and Vogelzang, Nicholas J
The lancet oncology, vol. 11, (no. 9), pp. 861-70, 2010/Sep. | Journal Article
 
Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma.
Sonpavde, Guru⋅Rosenberg, Jonathan E⋅Hahn, Noah⋅Galsky, Matthew D⋅Bangs, Rick⋅Sternberg, Cora N and Vogelzang, Nicholas J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 28, (no. 13), pp. e205-7; author reply e208, 2010/May/1. | Journal Article
2009
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
Hahn, Noah⋅Zon, R T⋅Yu, M⋅Ademuyiwa, Foluso O⋅Jones, T⋅Dugan, W⋅Whalen, C⋅Shanmugam, R⋅Skaar, T and Sweeney, Christopher J
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 20, (no. 12), pp. 1971-6, 2009/Dec. | Journal Article
 
Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.
Hahn, Noah M⋅Hahn, Noah⋅Reckova, Maria⋅Reckova, Maria⋅Cheng, Liang⋅Cheng, Liang⋅Baldridge, Lee Ann⋅Baldridge, Lee A⋅Cummings, Oscar W⋅Cummings, Oscar W⋅Sweeney, Christopher J and Sweeney, Christopher J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 27, (no. 3), pp. 460-3, 2009/Jan/20. | Journal Article
2007
Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.
Hahn, Noah⋅Hahn, Noah M⋅Kelley, Mark R⋅Kelley, Mark R⋅Klaunig, James E⋅Klaunig, James E⋅Koch, Michael O⋅Koch, Michael O⋅Li, Lang⋅Li, Lang⋅Sweeney, Christopher J and Sweeney, Christopher J
Future oncology (London, England), vol. 3, (no. 6), pp. 665-82, 2007/Dec. | Journal Article
2006
Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
Hahn, Noah M⋅Marsh, Sharon⋅Fisher, William⋅Langdon, Robert⋅Zon, Robin⋅Browning, Mark⋅Johnson, Cynthia S⋅Scott-Horton, Tiffany J⋅Li, Lang⋅Mc Leod, Howard and Sweeney, Christopher J
Clinical Cancer Research, vol. 12, (no. 20), pp. 6094-6099, 2006. | Journal Article
2005
Combined chemoradiotherapy in small cell lung cancer.
Hahn, Noah⋅Hahn, Noah M⋅Hanna, Nasser and Hanna, Nasser
Hematology/oncology clinics of North America, vol. 19, (no. 2), pp. 321-42, vii, 2005/Apr. | Journal Article
 
Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease.
Hahn, Noah and Sweeney, Christopher J
Urologic oncology, vol. 23, (no. 4), pp. 293-302, 2005 Jul-Aug. | Journal Article